Abstract
The prospect of genomic screening in newborns attracts both hype and criticism, but carefully designed, large-scale, prospective research studies are the only way to generate the data needed for its rigorous evaluation.
Original language | English |
---|---|
Pages (from-to) | 1823-1825 |
Number of pages | 3 |
Journal | Nature Medicine |
Volume | 30 |
Issue number | 7 |
Early online date | 19 Jun 2024 |
DOIs |
|
Publication status | Published - 1 Jul 2024 |
Keywords
- Cost-Benefit Analysis
- Genetic Testing/economics
- Genomics/economics
- Humans
- Infant, Newborn
- Neonatal Screening/economics
- Rare Diseases/genetics